The FDA's vaccine advisors will meet Thursday to vote on whether an XFG monovalent vaccine should be preferred for COVID-19 ...

One health system that implemented HPV self-collection kits saw a 2.2 percentage point increase in screening rates compared ...

VERVE-102 is an investigational gene-editing therapy designed to permanently turn off the PCSK9 gene in the liver to reduce LDL cholesterol. In a phase Ib study, a single infusion of the base-editing ...

President Donald Trump had another medical exam on Tuesday, putting his health under renewed public scrutiny as he has worked ...

Chronic hepatitis delta virus (HDV) infection has its first FDA-approved treatment, after the agency granted accelerated approval to bulevirtide (Hepcludex) injection for adults without cirrhosis or ...

Patients with obesity dropped a mean 28% of their body weight with a 12-mg dose of the investigational triple-receptor agonist retatrutide over 80 weeks in a phase III study, Eli Lilly announced.

This is the blind spot in bladder cancer care: not a lack of trust but the reality that important parts of the patient ...

States are monitoring additional people for potential hantavirus exposure, in many cases due to air travel, MedPage Today has ...

On the heels of the annual World Health Assembly in Geneva, let us quickly review today's public health scoreboard as the World Cup teams begin their travel to North America. On May 17, the World ...

The New York Times investigated the rapid expansion in autism therapy clinics in the U.S. with little regulatory oversight. Here are five takeaways from the report. Atomoxetine, metformin, isosorbide ...

The FDA on Friday approved datopotamab deruxtecan (Dato-DXd; Datroway) as a first-line option for unresectable or metastatic triple-negative breast cancer patients ineligible for immunotherapy.